Beyond Move Fast and Break Things: A Founder’s Guide to Healthtech Regulation

Navigating regulatory compliance in digital health requires moving past the “move fast and break things” mindset. From multi-state clinician network scaling and HIPAA-compliant data architectures to e-prescribing rules and clinical safety guardrails, early regulatory planning is essential. Rather than viewing compliance as a bottleneck, successful founders integrate legal strategy into their core product architecture from day one, avoiding costly fines, protecting patient safety, and building scalable, fundable healthtech enterprises.

Introduction: The Price of “Moving Fast and Breaking Things”

The principle “move fast and break things” dominated the software industry for years. If an error occurs when introducing a new consumer product, one can just fix it via an update and continue development. However, digital health development has many more complications than other industries, and non-compliance with prescribed rules can be dangerous for users, resulting in penalties from regulatory authorities, harming customers’ confidence, and even leading to business closures in some cases. In my experience collaborating and consulting with various technology and healthcare companies during the scaling up of their businesses, I have seen the severe impact non-compliance can have.

Yet, despite these risks, many digital health startups still address regulatory compliance after the product has been designed and implemented. This approach can result in costly delays and force teams to revisit decisions that have already been implemented. In digital health, legal and regulatory considerations are integral to product design and should be considered alongside the technology, user experience, and operational model from the outset. 

Pitfall 1: The “One-Size-Fits-All” Trap in Multi-State Scaling

One of the common assumptions made by early-stage founders in startups is that digital health startups can be rolled out at the national level under one regulatory system. 

However, in the United States, healthcare regulation is highly decentralized. There are differences between physician licensure, Corporate Practice of Medicine (CPOM) restrictions, telemedicine regulations, and prescription laws in different states. While the business may comply with all the requirements of the state of California, there might be discrepancies with the requirements of the state of New York or Texas. Such ignorance can cause delays and regulatory action.

The appropriate approach will depend on the states in which the business operates and its care model. This may involve using professional entity structures where required by CPOM rules, implementing robust clinician credentialing processes, or partnering with medical groups that are appropriately structured to operate across multiple jurisdictions. 

Pitfall 2: Treating Data Security and HIPAA as an Afterthought

Technical entrepreneurs may think that the presence of secure cloud infrastructure coupled with encryption technology will be sufficient to meet healthcare data privacy regulations. However, while cloud providers provide a secure infrastructure, that alone does not mean that your software will be compliant or secure.  

Underestimating the demands of HIPAA, the HITECH Act, or state-specific privacy law can be extremely expensive. Poor architecture of data pipelines, improper storage of PHI, and even marketing analytics processed by third parties can lead to data leaks and large fines.  

Compliance starts with building the security architecture around legal requirements, not around the finished product. When developing your platform, implement end-to-end encryption, multi-factor authentication, role-based access control, and comprehensive auditing. Partner only with HIPAA-compliant vendors, and sign Business Associate Agreements before sharing the PHI.

Pitfall 3: Overlooking Prescription and E-Prescribing Friction

Although D2C digital health platforms often tend to prioritize convenient user experience and creating a streamlined process for consultation and treatment, when the care model involves the prescription of any medications, it needs to follow strict regulations around digital prescriptions since they have a direct impact on the patient’s treatment beyond providing access to healthcare services.

Regulations are provided by state pharmacy boards and federal legislation such as the Ryan Haight Act, especially when controlled substances are concerned. Trying to eliminate the friction from your clinical process and maximize conversion rates by bypassing these regulations can result in immediate regulatory action, inability to prescribe through the chosen network, and serious harm to the company’s reputation.

For e-prescription tools, cooperating with compliant pharmacies that have an integrated e-prescription process and providing clinicians with the necessary tools for legally correct diagnostics and documentation before writing the e-prescription is hence essential.

Pitfall 4: Failing to Establish the Patient-Provider Relationship Compliantly

Contemporary digital products are often designed to reduce friction and increase conversions. Digital healthcare requires a more careful approach, as onboarding processes must balance user experience with the legal requirements governing medical consultations.

Establishing a legal patient-provider relationship is a prerequisite for diagnosis, treatment, and payment. The legal requirements for creating such a relationship vary across jurisdictions and treatment modalities. Whereas some jurisdictions may allow building relationships via asynchronous communications (filling questionnaires online, uploading photos), others require having a video session in order to start treatment and obtain reimbursement.

To overcome these differences, onboarding workflows must be adaptable and able to match the legal requirements of particular jurisdictions. This often requires building in smart conditional logic into the product experience. If a person logs in to your website from a jurisdiction that requires a live clinical consultation, the program should offer a video chat window rather than performing the asynchronous intake. 

The Liability Frontier: Clinical Safety Protocols and Digital Malpractice Guardrails

Beyond issues related to licensing, privacy, prescribing, and patient onboarding, there is still one more regulatory risk involved in the use of your software: the clinical decisions made through your tool. With the increasing complexity of digital health platforms, the operational risks begin to move from the area of technical security to clinical decisions. The inclusion of triage algorithms, decision support tools, and symptom intake screeners leads to clinical risks for your platform.

To mitigate this risk, founders need to include clinical safety guardrails in their processes. The algorithm needs to be programmed to flag potential danger symptoms in a patient and automatically redirect the patient to clinicians or local emergency departments. These safeguards can reduce the risk of software contributing to an unsafe clinical outcome, but they do not eliminate the potential for liability. Founders should therefore consider how clinical risks are addressed not only through product design and operational protocols but also through appropriate insurance coverage. Traditional technology Errors and Omissions (E&O) insurance typically does not cover claims arising from medical malpractice, making appropriate malpractice coverage an important consideration for digital health companies.

Conclusion: Proactive Compliance is Your Launchpad

Regulatory errors in digital health can be largely prevented by careful planning and embedding the necessary regulatory requirements from the very beginning. In my experience advising companies through financings, mergers, and IPOs, sophisticated investors and corporate partners rarely view regulatory compliance as an obstacle. Instead, strong compliance demonstrates operational maturity, sound governance, and readiness for sustainable growth.

In digital health, the combination of technological innovation with strong governance is critical for sustainable growth. Startups that regard regulatory compliance as a strategic competence are more likely to be able to inspire trust among patients, pass the investor’s due diligence procedure, establish partnerships with providers, and enter new markets successfully.